Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease:

Justin Lee Mifsud1,2, John Stephenson3, Felicity Astin3,4

  • 1Faculty of Health Sciences, University of Malta, Msida, Malta. justin-lee.mifsud@um.edu.mt.

Insights

This pilot study tested a new intervention for relatives of heart disease patients in Malta. The program showed potential for improving cardio-protective lifestyles in high-risk individuals.

Area of Science:

  • Preventive Cardiology
  • Cardiovascular Disease Risk Reduction
  • Health Behavior Interventions

Background:

  • Preventive cardiology programs often show limited success in promoting healthy practices among high-risk individuals.
  • First-degree relatives of patients with premature coronary heart disease (CHD) are at increased risk of atherosclerotic cardiovascular disease (ASCVD).
  • Malta currently lacks specific programs to support this high-risk population.

Purpose of the Study:

  • To determine the feasibility and acceptability of a novel preventative intervention for first-degree relatives of patients with premature CHD.
  • To assess the potential effectiveness of the intervention in reducing modifiable cardiovascular risk factors.
  • To inform the design of a definitive trial for this population.

Main Methods:

  • A 12-month, single-centre, two-armed group randomized controlled trial (RCT) involving 100 asymptomatic first-degree relatives.
  • Intervention group received risk communication, motivational interviewing, and telephone goal reinforcement.
  • Control group received only verbal lifestyle advice; feasibility assessed by recruitment/retention; qualitative interviews conducted.

Main Results:

  • The study assessed changes in risk factors at baseline, 6, and 12 months.
  • Qualitative interviews explored participant experiences and intervention acceptability.
  • Descriptive statistics were used to assess associations between variables.

Conclusions:

  • The intervention is hypothesized to lead to greater cardio-protective lifestyle improvements compared to standard advice.
  • This is the first trial of its kind among Maltese first-degree relatives, addressing a critical research gap.
  • Results will guide a future definitive trial on preventing cardiovascular disease in this at-risk group.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
422
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
74
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
537
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
53
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
587
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
62